High
0.490
Open
0.4656
VWAP
0.48
Vol
204.29K
Mkt Cap
13.77M
Low
0.4656
Amount
98.42K
EV/EBITDA(TTM)
--
Total Shares
16.85M
EV
24.07M
EV/OCF(TTM)
--
P/S(TTM)
0.18
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q4
FY2025Q1
14.50M
-8.46%
--
--
15.50M
+6.28%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Cosmos Health Inc. (COSM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 19.72%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+19.72%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Cosmos Health Inc (COSM.O) is 44.03, compared to its 5-year average forward P/E of 0.55. For a more detailed relative valuation and DCF analysis to assess Cosmos Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.55
Current PE
44.03
Overvalued PE
10.75
Undervalued PE
-9.65
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-2.56
Current EV/EBITDA
7.08
Overvalued EV/EBITDA
6.01
Undervalued EV/EBITDA
-11.12
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.18
Current PS
0.18
Overvalued PS
0.44
Undervalued PS
-0.07
Financials
Annual
Quarterly
FY2025Q1
YoY :
-5.98%
13.71M
Total Revenue
FY2025Q1
YoY :
-54.62%
-833.15K
Operating Profit
FY2025Q1
YoY :
-56.17%
-818.10K
Net Income after Tax
FY2025Q1
YoY :
-72.73%
-0.03
EPS - Diluted
FY2025Q1
YoY :
-94.27%
-200.12K
Free Cash Flow
FY2025Q1
YoY :
+81.44%
12.61
Gross Profit Margin - %
FY2025Q1
YoY :
-70.86%
-10.62
FCF Margin - %
FY2025Q1
YoY :
-53.36%
-5.97
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
260.0K
USD
Months
3-6
8
836.0K
USD
Months
6-9
9
539.0K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
260.0K
USD
Months
3-6
8
836.0K
USD
Months
6-9
9
539.0K
USD
Months
0-12
0
0.0
USD
Months
COSM News & Events
Events Timeline
2025-06-24 (ET)
2025-06-24
10:59:17
Cosmos Health enters U.S. market with DolCas Biotech agreement
2025-05-15 (ET)
2025-05-15
09:39:20
Cosmos Health reports Q1 EPS (3c) vs. (11c) last year
2025-05-06 (ET)
2025-05-06
13:45:41
Cosmos Health receives additional 180-cay compliance period from Nasdaq
Sign Up For More Events
Sign Up For More Events
News
9.5
05-15NASDAQ.COMCosmos Health Reports Strong Q1 2025 Financial Performance and Improved Profitability Metrics
6.0
05-07NewsfilterCosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
7.0
05-06NewsfilterCosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
Sign Up For More News
People Also Watch
BOLT
Bolt Biotherapeutics Inc
5.950
USD
+3.75%
GOEV
Canoo Inc
0.370
USD
0.00%
XTIA
XTI Aerospace Inc
2.110
USD
-2.31%
DUO
Fangdd Network Group Ltd
2.320
USD
+5.94%
NXTT
Next Technology Holding Inc
2.350
USD
-2.49%
COEP
Coeptis Therapeutics Holdings Inc
10.910
USD
+1.96%
MEIP
MEI Pharma Inc
6.860
USD
+4.73%
WETH
Wetouch Technology Inc
0.900
USD
+0.56%
NRXS
Neuraxis Inc
2.860
USD
+4.76%
COHN
Cohen & Company Inc
12.010
USD
+4.43%
FAQ
What is Cosmos Health Inc (COSM) stock price today?
The current price of COSM is 0.4789 USD — it has decreased -0.21 % in the last trading day.
What is Cosmos Health Inc (COSM)'s business?
What is the price predicton of COSM Stock?
What is Cosmos Health Inc (COSM)'s revenue for the last quarter?
What is Cosmos Health Inc (COSM)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Cosmos Health Inc (COSM)'s fundamentals?
How many employees does Cosmos Health Inc (COSM). have?